Impedimed Limited ( (AU:IPD) ) has issued an update.

Impedimed Limited has announced the cessation of 11,642,750 options and 8,529,911 performance rights after the conditions attached to these securities were not met or became incapable of being satisfied by 30 June 2026. The lapse of these conditional securities effectively reduces the company’s potential future dilution, clarifies its issued capital structure, and may signal a reset of its equity-based incentive arrangements for management and staff.

The move provides investors with greater transparency over Impedimed’s capital base and the status of its long-term incentive instruments. By formally recording the expiry of these options and performance rights, the company aligns its reported capital position with current realities, which may influence perceptions of future share supply and the alignment of executive incentives with shareholder interests.

The most recent analyst rating on (AU:IPD) stock is a Buy
with a A$0.02 price target.
To see the full list of analyst forecasts on Impedimed Limited stock,
see the AU:IPD Stock Forecast page.